Data / Drug companies / Homosalate, octisalate, avobenzone, octocrylene
Homosalate, octisalate, avobenzone, octocrylene: 7 companies and 9 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Homosalate, octisalate, avobenzone, octocrylene is listed in the FDA National Drug Code Directory by 7 companies, with 9 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are cream; liquid; gel, and the newest product started marketing on June 28, 2024.
The request: Get every company that lists homosalate, octisalate, avobenzone, octocrylene in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 7
- Products
- 9
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 2
- Routes
- Topical
- Brand names
- Beauty 360 Accelerated Wrinkle Repair Moisturizer, Invisible Sunscreen SPF 40, Herbal Uv Defense SPF40, Cellular Laboratories De-Aging Sunscreen Broad Spectrum SPF 50 Plus, 3lab Perfect Sunscreen SPF 50 Plus Broad Spectrum, 3lab WW Day SPF40 Broad Spectrum, Nia 24 SPF 30
- openFDA record search
- api.fda.gov
Companies that list homosalate, octisalate, avobenzone, octocrylene
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| 3lab, Inc | 2 | cream | Over the counter monograph drugs | May 27, 2016 |
| Cosmax USA, Corporation | 2 | gel; cream | Over the counter monograph drugs | June 28, 2024 |
| Amcol Health & Beauty Solutions, Inc. DBA | 1 | liquid | Over the counter monograph drugs | April 1, 2016 |
| CVS Pharmacy | 1 | liquid | Over the counter monograph drugs | April 1, 2017 |
| Market America | 1 | cream | Over the counter monograph drugs | May 3, 2011 |
| Niadyne Inc | 1 | lotion | Over the counter monograph drugs | June 9, 2011 |
| Particle Aesthetic Science LTD | 1 | cream | Over the counter monograph drugs | June 28, 2024 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Cream | 5 | 55.6% |
| Liquid | 2 | 22.2% |
| Gel | 1 | 11.1% |
| Lotion | 1 | 11.1% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 9 | 100% |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.